期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
TREM2单克隆抗体的制备及应用检测
1
作者 马宾 孟麟 +2 位作者 戎卓娜 赵传科 寿成超 《中国免疫学杂志》 CAS CSCD 北大核心 2024年第1期168-173,177,共7页
目的:制备TREM2特异性单克隆抗体并对其特异性、亲和力及在免疫学检测中的应用进行鉴定,为TREM2的抗体药物研发奠定基础。方法:表达并纯化TREM2胞外段GST融合蛋白,用其作为抗原免疫小鼠,筛选抗血清效价较高的小鼠,经过细胞融合和单克隆... 目的:制备TREM2特异性单克隆抗体并对其特异性、亲和力及在免疫学检测中的应用进行鉴定,为TREM2的抗体药物研发奠定基础。方法:表达并纯化TREM2胞外段GST融合蛋白,用其作为抗原免疫小鼠,筛选抗血清效价较高的小鼠,经过细胞融合和单克隆筛选,制备TREM2的特异性单克隆抗体。对获得的单克隆抗体的特异性、亲和力及其在免疫学实验中的应用进行检测。结果:获得了29株TREM2单克隆抗体,其中的24株可与TREM2特异性结合;29株单抗与TREM2结合的EC50均在nmol以上;它们可分别在Western blot、免疫沉淀、流式细胞术和免疫荧光中用于对TREM2的特异检测。结论:成功制备并获得了亲和力高、特异性好的抗TREM2单克隆抗体,为TREM2靶点的成药性抗体开发奠定了基础。 展开更多
关键词 TREM2 单克隆抗体 制备 鉴定
下载PDF
利用DNA免疫技术制备人CLDN18.2单克隆抗体 被引量:1
2
作者 戎卓娜 赵传科 +4 位作者 孟麟 王冰 钟堂武 王立新 寿成超(指导) 《中国免疫学杂志》 CAS CSCD 北大核心 2022年第19期2378-2383,共6页
目的:制备CLDN18.2特异性单克隆抗体并对其特性和在免疫检测中的应用进行鉴定,为CLDN18.2的抗体药物研发奠定基础。方法:将in vivo-jetPEI-Gal和pcDNA3.1-CLDN18.2质粒在体外混合后经尾静脉免疫小鼠,筛选效价较高的小鼠进行细胞融合和... 目的:制备CLDN18.2特异性单克隆抗体并对其特性和在免疫检测中的应用进行鉴定,为CLDN18.2的抗体药物研发奠定基础。方法:将in vivo-jetPEI-Gal和pcDNA3.1-CLDN18.2质粒在体外混合后经尾静脉免疫小鼠,筛选效价较高的小鼠进行细胞融合和单克隆筛选,制备CLDN18.2的特异性单克隆抗体,然后对获得的单克隆抗体的亲和力和特异性及其在细胞ELISA、流式细胞术、细胞免疫荧光和免疫沉淀等实验中的应用进行鉴定。结果:共获得15株有较好特异性的CLDN18.2单克隆抗体,其与CLDN18.2结合的EC50s均在纳摩尔或亚纳摩尔级,可在ELISA、免疫沉淀、流式细胞术和细胞免疫荧光实验中用于对CLDN18.2的特异检测,但均不能用于Western blot实验。结论:成功制备并获得了15株可识别蛋白天然构象、亲和力高、特异性好的小鼠抗人CLDN18.2单克隆抗体,为CLDN18.2抗体药物的研发奠定了重要基础。 展开更多
关键词 CLDN18.2 DNA免疫 单克隆抗体 制备 鉴定
下载PDF
Establishment of a high-throughput screening system for universal anti-HIV targets 被引量:3
3
作者 YIN Qi ZHUANG DaoMing +3 位作者 JIANG YaQin zhao chuanke ZENG Xin LI ShiYou 《Chinese Science Bulletin》 SCIE EI CAS 2010年第10期937-942,共6页
The process of identifying novel human immunodeficiency virus 1 (HIV-1) inhibitors presents a challenge for industrial and scientific research.Virus-cell-based screening approaches offer some advantages in the quest f... The process of identifying novel human immunodeficiency virus 1 (HIV-1) inhibitors presents a challenge for industrial and scientific research.Virus-cell-based screening approaches offer some advantages in the quest for novel inhibitors because they include multiple targets in a single screen and in some cases reveal targets not captured in biochemical assays.In this study,a high-throughput screening (HTS) system for HIV-1 inhibitors was developed,which allows the simultaneous screening of all the HIV-1 targets required for replication in the cell culture.HeLa/cluster of differentiation 4 (CD4)/long terminal repeat (LTR) indicator cells,which stably expressed high levels of HIV receptor CD4 and contained the firefly luciferase reporter gene under the control of the HIV-1 LTR promoter,were generated.The expression of CD4 and LTR function in this cell line was validated by Western blot and luciferase assay.MT2 cells,a human T-cell leukemia cell line that support high levels of HIV-1 replication,were infected with HIV-1,and then the infected MT2 cells were co-cultured with HeLa/CD4/LTR cells.In the optimized assay conditions,HIV-1 replication occurs rapidly in the MT2 cells,resulting in the infection of the HeLa/CD4/LTR cells and a significant induction of luciferase signals through LTR,which is activated by the expression of HIV-1 tat gene.The luciferase signals of HeLa/CD4/LTR cells co-cultured with HIV-1 infected MT2 cells were significantly stronger than the signals of noninfected HeLa/CD4/LTR cells (P < 0.001).The inhibitory effects of HIV-1 inhibitors (3'-Azido-3'-deoxythymidine [AZT],efavirenz [EFV],and nevirapine [NVP]) were evaluated with this assay,and the inhibitory concentration 50% (IC50) values of the above three inhibitors were 58,1.4,and 85 nmol/L,respectively,indicating that the assay provides the necessary sensitivity for identifying antiviral molecules.The Z' factor had a value of 0.563,indicating this is a very robust assay.These results suggested that HIV-1 infection assay represents a novel approach to HIV-1 antiviral screening that allows for the effective execution of HTS campaigns. 展开更多
关键词 HIV-1 高产量的屏蔽 禁止者 virus-cell-based 试金
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部